Kimberly-Clark is merging with Kenvue, creating a larger-scale company with a $32 billion global leader in health and wellness. The deal values Kenvue at $48.7 billion and aims to save money but comes with risks. The transaction is expected to close in the second half of next year.

The merger between Kimberly-Clark and Kenvue brings together two companies with long histories of growing dividends. Both are Dividend Kings, each with over 50 years of consecutive annual payout increases. The deal will create a stronger income stock for long-term investors.

Kimberly-Clark will acquire Kenvue using a mix of cash and stock, valuing Kenvue at $48.7 billion. Shareholders will receive $3.50 in cash and 0.14625 shares of Kimberly-Clark for each Kenvue share. Existing Kimberly-Clark shareholders will own about 54% of the combined company after the deal.

The combined company will generate $32 billion in annual revenue, making it the second-largest player in health and wellness behind Procter & Gamble. The deal is expected to bring about $2.1 billion in net benefits within four years through cost and revenue synergies.

While the merger will create a larger-scale company, it will also help address the legal and market challenges Kenvue has faced since becoming independent in 2023. The deal aims to strengthen the combined company’s position in the market.

While the merger presents opportunities for growth, there are risks involved. Kenvue has faced legal challenges, including potential lawsuits related to its products. These issues could impact the stock price and dividend growth of the combined company.

The merger between Kimberly-Clark and Kenvue is expected to deliver cost savings and address legacy legal issues. While the deal carries risks, the larger-scale combined company will be better positioned to enhance shareholder value in the future.

Read more at Yahoo Finance: These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors?